# Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

> **NCT00772915** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 39 (actual)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00772915
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-03
- **Primary completion:** 2011-03-22
- **Final completion:** 2018-06-27
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772915, "Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00772915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*